Multicenter prospective cohort study to reveal the incidence and risk factors of venous thromboembolism in Japanese patients with IBD.

Multicenter prospective cohort study to reveal the incidence and risk factors of venous thromboembolism in Japanese patients with IBD. - Multicenter prospective cohort study for venous thromboembolism in Japanese IBD patients.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030524

Enrollment

120

Registered

2017-12-25

Start date

2014-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients of any age (male or female) 2. Patients who agree to participate this study after receiving an explanation and providing consent forms If target patients are under 20 years of age, the legal representative (parents and so on) needs to agree with their participation in this study after receiving an explanation and providing consent forms. 3. Patients who admit to a hospital. 4. Patients who admit for the reason of developing VTE can be registered in this study. 5. Patients with pouchitis after colectomy for UC can be registered in this study. 6. Patients who have either benign or malignant disorder in the group with other digestive disease can be registered.

Exclusion criteria

Exclusion criteria: 1. IBD patients to whom steroids, immunomodulators and biologics need to be administrated for the treatments of disease other than IBD and IBD-related manifestation. 2. Patients who need to receive intensive care for severe complications such as cardiovascular disorder (heart failure, acute coronary syndrome and so on) and pulmonary disorder (respiratory failure, severe pneumonia, bronchial asthma intussusception and so on). 3. Patients with restrictions on their activities, who have malignant tumor with distant metastasis, severe organ failure or are in a terminal state. 4. Patients who are not confirmed to have a diagnosis of IBD, such as IBD unclassified. 5. Patients who do not agree to participate in this study regardless of having received an explanation and consent forms.

Design outcomes

Primary

Measure	Time frame
The incidence of venous thromboembolism in inpatients with IBD.	—

Secondary

Measure	Time frame
1. Risk of onset for VTE in IBD compared with that in other digestive diseases 2. The site of VTE development, treatment for VTE, outcome of VTE 3. The risk factors of VTE in IBD	—

Countries

Japan

Contacts

Public ContactKatsuyoshi Ando

Asahikawa Medical University Department of Community Medicine Management

k-ando@asahikawa-med.ac.jp0166-68-2462

Outcome results